Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 0.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.97 | 2.26 |
NAV | ₹15.99 | ₹148.10 |
Fund Started | 01 Feb 2022 | 13 Oct 2005 |
Fund Size | ₹2334.85 Cr | ₹1385.43 Cr |
Exit Load | 0.5% for redemption within 90 Days | Exit load of 1% if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 3.24% | 11.71% |
3 Year | - | 17.73% |
5 Year | - | 20.63% |
1 Year
3 Year
5 Year
Equity | 96.65% | 94.94% |
Cash | 3.35% | 3.99% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 5.23% |
Reliance Industries Ltd. | 4.06% |
Mahindra & Mahindra Ltd. | 3.52% |
Tata Steel Ltd. | 3.17% |
Dr. Reddy's Laboratories Ltd. | 2.74% |
Coromandel International Ltd. | 2.71% |
Hindustan Petroleum Corporation Ltd. | 2.61% |
Larsen & Toubro Ltd. | 2.56% |
Hindalco Industries Ltd. | 2.55% |
Bharat Electronics Ltd. | 2.54% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.60% |
Axis Bank Ltd. | 6.91% |
Reliance Industries Ltd. | 5.65% |
Bharti Airtel Ltd. | 5.45% |
HDFC Bank Ltd. | 4.98% |
State Bank of India | 4.97% |
NTPC Ltd. | 4.55% |
Larsen & Toubro Ltd. | 4.01% |
Infosys Ltd. | 3.95% |
Sun Pharmaceutical Industries Ltd. | 3.17% |
Name | Harsha Upadhyaya | Sri Sharma |
Start Date | 01 Oct 2023 | 01 May 2023 |
Name
Start Date
Description | The scheme seeks to generate capital appreciation by investing in a diversified portfolio of companies that follow the manufacturing theme. | The scheme seeks to generate capital appreciation and income distribution to unit holders by investing predominantly in equity/equity related securities of the companies belonging to Exports & Services industry. |
Launch Date | 01 Feb 2022 | 13 Oct 2005 |
Description
Launch Date